The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
about
Regulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in CancerThe role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progressionMechanisms of genome instability induced by RNA-processing defects.Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.The splicing activator DAZAP1 integrates splicing control into MEK/Erk-regulated cell proliferation and migration.Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.A role for the serine/arginine-rich (SR) protein B52/SRSF6 in cell growth and myc expression in DrosophilaDMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancerHuman Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in CancerComparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancerPTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells.Genome-wide genetic investigation of serological measures of common infectionsGenome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.The impact of RNA binding motif protein 4-regulated splicing cascade on the progression and metabolism of colorectal cancer cells.Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.RNA splicing factors as oncoproteins and tumour suppressors.High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.Frequent L1 retrotranspositions originating from TTC28 in colorectal cancer.Regulation of splicing by SR proteins and SR protein-specific kinases.Alternative splicing of DNA damage response genes and gastrointestinal cancers.BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma developmentSplicing-factor alterations in cancers.The role of RNA alternative splicing in regulating cancer metabolism.A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1The translational landscape of the splicing factor SRSF1 and its role in mitosis.Pathway analysis of cervical cancer genome-wide association study highlights the MHC region and pathways involved in response to infection.SRp55 Regulates a Splicing Network that Controls Human Pancreatic Beta Cell Function and Survival.Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Q58714425
P2860
Q27001635-D8F7BBE8-B968-4B1C-8190-05CF17AE27C6Q28083838-F37FF82B-3EA1-4E53-A66C-EAAA115F7FE2Q33691010-2606D37A-3FE1-4BA4-A70E-B75EF75D84A7Q34040857-44D44B75-C1FE-4ECD-9C75-2FF1072062E9Q34097169-E67A6FCF-D676-49B7-89A9-344DA32DA949Q34240895-2CBA5C3F-67F4-4436-B470-3EC83866AE4DQ35342607-49ED25DE-EF8C-44D9-849A-C144CD3591BCQ35434433-72F7C019-3AB9-47C2-8D35-34EAA129D7DAQ35641431-03BB61F6-361C-479A-A5A8-0F35D5B57A44Q35801261-08A58527-8E08-4095-AD97-4280B045508DQ36022146-4DC531EF-D8E5-41CF-9055-8579D833C107Q36047336-D3A9B531-2693-461B-B764-5432D57C7F3DQ36101955-78256858-FBD5-4DF2-AB45-8702EB28029DQ36184615-A8743201-4D2E-430D-A859-041CEFBC9475Q36355909-B341AE99-B7B0-4AB3-90F0-5B52D1685AC3Q36545961-32C4E523-6A64-465A-8DA9-A9D90227D5E0Q37304724-7A75CA80-7AAF-4D89-A3F8-CA986D5D97F9Q37390636-F06A05F4-A985-45AB-A383-9A23045A5071Q37391660-83335C58-8735-4A70-9D23-0CB001429D1DQ37510247-EBEC02F9-684F-4C26-8699-2782777CD3BBQ37690348-9C06B5BC-0829-4CC4-802B-49AD7A3B7902Q37702711-654F6C9C-6FAD-4524-B026-9F60DED6BEBFQ37718433-70DC6A9F-31AB-47AA-A340-E365C272EDBDQ38092678-805B5A1B-25A7-40AF-B8F6-2EE99FD1C2A7Q38291477-6D2E5FF5-B35F-48D5-B4B1-07CF1BED33FEQ38305268-5C901CDE-7E02-4679-AB05-776CB29203B4Q38487106-066601F4-717D-4624-A500-0A4744AA9200Q38929098-4350BC98-B867-4F6C-A423-5B584ED3D688Q39253959-10943EA7-744E-44AA-A71F-7A627CC8F404Q39787266-ACCBD150-36D0-4FED-A070-9107586C7087Q39787845-2BB5920C-83B0-4DE7-B49F-DB35109B9BBEQ42212169-DA576358-B0F4-4569-A84C-AA5E666DC5E4Q47287555-5B538B1D-2CCC-4A21-98C7-4B6D8BC1EA34Q47784889-E06B8003-4AFC-49BE-8DA9-85051B472B95Q52564290-778CA76D-9380-4C9A-ABBE-2C1576AA4EB6Q58714425-4ADA35B0-A175-4C1A-A2F8-5A730EB21159
P2860
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@ast
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@en
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@en-gb
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@nl
type
label
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@ast
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@en
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@en-gb
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@nl
prefLabel
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@ast
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@en
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@en-gb
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@nl
P2093
P2860
P921
P3181
P356
P1476
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
@en
P2093
Kasper Thorsen
Michal Cohen-Eliav
Regina Golan-Gerstl
Rotem Karni
Torben F Ørntoft
Zahava Siegfried
P2860
P3181
P356
10.1002/PATH.4129
P407
P577
2013-03-01T00:00:00Z